Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study for Identifying a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged Less ≤90 Days

NCT01888471 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01888471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01888471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study for Identifying a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged Less ≤90 Days
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2013
Completion date
July 14, 2014
Enrollment
3,033 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

streptococcus agalactiae